AzTrials
AzTrials

Alcohol Use DisorderNCT05630118

Online Insomnia Intervention to Reduce Alcohol Use

A study testing SHUTi Intervention and Web-Based Insomnia Education Program in people with Alcohol Use Disorder and Heavy Drinking, run by Jessica Weafer at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

Alcohol use disorder (AUD) inflicts enormous physical, emotional, and financial burdens on the individual and society at large. Insomnia is highly prevalent among individuals with AUD, and disrupted sleep contributes substantially to alcohol-related problems. Read more about this study

Who is it for?
Ages 18 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Alcohol Use Disorder, Heavy Drinking
What is being tested?
SHUTi Intervention and Web-Based Insomnia Education Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
113 participants
Where
1 siteUnited States
Study dates
24 Jan 2023to 7 Jul 2025
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • 18-50 years old
  • Fluency in English
  • At least weekly binge drinking episodes (4/5+ drinks for women/men)]
  • Insomnia Severity Index (ISI) scores #15

Who cannot join

  • No internet access
  • Past or current substance use disorder (other than mild or moderate AUD)
  • Obstructive sleep apnea
  • Bipolar disorder, schizophrenia, or other psychotic spectrum disorder
  • Pregnancy or nursing for women
  • Any serious medical or neurological problems

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University Of Kentucky Psychology Research Lab

    Lexington, Kentucky, 40504

Other trials in United States

About this study

Official title: Testing an Online Insomnia Intervention to Reduce Alcohol Use Via Improved Sleep Among Heavy Drinkers

Alcohol use disorder (AUD) inflicts enormous physical, emotional, and financial burdens on the individual and society at large. Insomnia is highly prevalent among individuals with AUD, and disrupted sleep contributes substantially to alcohol-related problems. While research suggests that treating insomnia may effectively reduce AUD, the degree to which treating insomnia in heavy drinkers reduces alcohol consumption and prevents the onset of severe AUD is not known. This study will be the first to evaluate an Internet-based version of cognitive behavioral therapy for insomnia (CBT-I) in community-dwelling, heavy drinking adults with insomnia. Sleep Healthy Using the Internet (SHUTi), the most widely-used and well-validated version of Internet-based CBT-I will be used. The primary aim is to reduce alcohol consumption and insomnia severity in this population.

Read the detailed description

The study will investigate the efficacy of Sleep Healthy Using the Internet (SHUTi), an online insomnia intervention, in reducing alcohol consumption and improving sleep in heavy drinkers with insomnia. The participants are ages 18-50 (N=100) who have insomnia and are heavy drinkers (at least weekly binge drinking episodes [4/5+ drinks in one sitting for men/women]). This intervention has a mixed methods randomized controlled trial design. Participants will be randomly assigned to either the online SHUTi intervention (N=50), or a patient education (PE) website (N=50). Quantitative data will be collected via online REDCap surveys and daily online diaries. Qualitative data will be collected via semi-structured telephone interviews. Data collection points will be pre-intervention, post-intervention, and 3- and 6-months postintervention.

Being tested
SHUTi Intervention, Web-Based Insomnia Education Program
Keywords
Sleep, Cognitive Behavioral Therapy, CBT, Alcohol, App, Non Pharmacological
Medical subject headings
Alcoholism, Alzheimer Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SHUTi InterventionBehavioural

    Sleep Healthy Using the Internet (SHUTi) is a well-validated version of e-CBT-I comprised of 6 weekly educational modules and daily sleep diaries. Participants will have 9 weeks to complete 6 once-weekly educational "cores." Cores consist of: insomnia overview, sleep restriction, stimulus control, cognitive restructuring, sleep hygiene, and relapse prevention, and last approximately 45 minutes each. Participants will receive weekly objectives, as well as review and feedback on the previous core's assignments and sleep diary data, new material, assignments, and a summary. These features are supplemented with interactive features (i.e., personalized goal-setting, video vignettes). Participants receive daily emails prompting them to complete the 11-item sleep and alcohol use diary daily during the intervention.

  • Web-Based Insomnia Education ProgramBehavioural

    Participants will be given access to a web-based program on sleep education to read at their own pace during the 9-week intervention period. The program content overlaps with SHUTi on the following topics: insomnia symptoms, impacts, and causes, basic sleep improvement strategies, and when to see a doctor. The information is akin to that found on WebMD or National Sleep Foundation website. Unlike the SHUTi program, the information is fixed, accessible immediately (no week-to-week information "unlocking") and there are no customized bedtime or wake-time suggestions based on sleep diary data.

Study groups in NCT05630118
Study groupRoleWhat they receive
SHUTi InterventionExperimentalAdult heavy drinkers with insomnia
Receives: Behavioral: SHUTi Intervention
Web-Based Insomnia Education ProgramActive comparatorAdult heavy drinkers with insomnia
Receives: Behavioral: Web-Based Insomnia Education Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change In Alcohol Use: 1) Total Number of Drinking Days (DD)

    Participants reported daily alcohol use on a daily alcohol diary, including whether alcohol was consumed each day. Daily responses were used to calculate the total number of drinking days during the assessment period.

    Measured: 33 weeks (baseline, at the end of the 9-week intervention, and 6-months post-intervention)

  2. Change In Alcohol Use: 2) Average Number of Drinks Per Drinking Day (DPDD).

    Participants will report the number of drinks consumed each day on a daily alcohol diary.

    Measured: 33 weeks (baseline, at the end of the 9-week intervention, and 6-months post-intervention)

  3. Change In Alcohol Use: 3) Total Number of Drinks (TD).

    Participants will report the number of drinks consumed each day on a daily alcohol diary.

    Measured: 33 weeks (baseline, at the end of the 9-week intervention, and 6-months post-intervention)

  4. Change In Alcohol Use: 4) Total Number of Binge Episodes (HDD)

    Participants will report the number of drinks consumed each day on a daily alcohol diary. Summary measures will include total number of binge episodes (4/5+ drinks for women/men) over a 10-day period.

    Measured: 33 weeks (baseline, at the end of the 9-week intervention, and 6-months post-intervention)

  5. Change In Sleep: Insomnia Severity Index (ISI)

    The ISI uses a 7-item scale to asses insomnia impact over the previous two weeks. Items scores range from 0-28. Scores indicate moderate to severe insomnia. Moderate or marked clinical improvement is indicated by a change score of >7 or >8 respectively. Higher scores on the ISI mean worse sleep (more severe insomnia).

    Measured: 33 weeks (baseline, at the end of the 9-week intervention, at 3- and 6-months post-intervention)

  6. Change In Sleep: 2) Pittsburgh Sleep Quality Index (PSQI)

    The PSQI indexes one-month global sleep quality using 18 items scored on a scale from 0-21. On the PSQI, higher scores mean worse sleep quality.

    Measured: 33 weeks (baseline, at the end of the 9-week intervention, at 3- and 6-months post-intervention)

  7. Change In Sleep: 3) Daily Sleep Diaries

    Sleep Onset Latency (SOL). Participants will report how long it took them to fall asleep.

    Measured: 33 weeks (baseline, at the end of the 9-week intervention, and 6-months post-intervention)

  8. Change In Sleep: 4) Daily Sleep Diaries

    Wake after Sleep Onset (WASO): Participants will report the number of minutes awake after falling asleep.

    Measured: 33 weeks (baseline, at the end of the 9-week intervention, and 6-months post-intervention)

  9. Change in Medication Use: 5) Daily Sleep Diaries

    Participants will report the amount of sleep medication used each day.

    Measured: 33 weeks (baseline, at the end of the 9-week intervention, and 6-months post-intervention)

Secondary outcomes (2)
  1. Change In Mood: 1) Perceived Stress Scale (PSS)

    The PSS will assess perceived stress over the prior month. Scores range from 0-40. The PSS demonstrates strong concurrent and predictive validity for various health behaviors and outcomes with higher scores indicating greater psychological distress.

    Measured: 33 weeks (baseline, at the end of the 9-week intervention, at 3- and 6-months post-intervention)

  2. Change In Mood: 2) Center for Epidemiologic Studies Depression Scale-Revised (CESD-R-10)

    The CESD-R-10 will index past-week depressive symptoms. Scores range from 0-30. Higher scores represent more severe symptoms.

    Measured: 33 weeks (baseline, at the end of the 9-week intervention, at 3- and 6-months post-intervention)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Nov 2022
  2. Study start24 Jan 2023
  3. Primary completion7 Jul 2025
  4. Study completion7 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
113 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05630118
Sponsor's protocol ID
60446-2
Other IDs
1R21AA029201-01A1
Status last verified
Jul 2026
First submitted
17 Nov 2022
Last updated
15 Jul 2026
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in